Literature DB >> 7484834

Incidence of infective endocarditis in the Delaware Valley, 1988-1990.

J A Berlin1, E Abrutyn, B L Strom, J L Kinman, M E Levison, O M Korzeniowski, R S Feldman, D Kaye.   

Abstract

This population-based study aimed to determine the incidence of native, prosthetic, and bioprosthetic valve nosocomial infective endocarditis (IE), and IE associated with the use of injected drugs. Patients with IE during 27 months over the years 1988 to 1990, and residing in any of 6 counties in the Philadelphia metropolitan area were identified. An expert panel reviewed all patients to verify the diagnosis. Incidence rates were estimated after adjustment for failure to recruit and underreporting. Of 853 potential patients, 670 (79%) met the inclusion criteria. The overall incidence rate of IE was 11.6 cases/100,000 person-years (95% confidence interval [CI] 10.8 to 12.4). The rates for specific types of IE were: 4.45 (95% CI 3.97 to 4.94) for community-acquired native valve, 0.94 (95% CI 0.72 to 1.12) for prosthetic valve, 0.94 (95% CI 0.71 to 1.16) for nosocomial, and 5.34 (95% CI 4.80 to 5.87) for IE associated with use of injected drugs. Previous population studies found overall incidence rates of 1.7 to 4 cases/100,000 person-years, similar to our rate for community-acquired native valve IE. Type-specific rates have not been previously reported. The higher overall rate in this study is partly related to the high prevalence of injection drug use in our area.

Entities:  

Mesh:

Year:  1995        PMID: 7484834     DOI: 10.1016/s0002-9149(99)80264-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Infective Endocarditis: Current Guidelines on Prophylaxis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Infective endocarditis and perivalvular abscess: a dangerous duo.

Authors:  Stephen D Shafran
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

3.  Update on echocardiography in the management of infective endocarditis.

Authors:  John Francis Sedgwick; Darryl John Burstow
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 4.  Epidemiology and antibiotic treatment of infective endocarditis: an update.

Authors:  Bruno Hoen
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

5.  The risk of infective endocarditis in the 21st century.

Authors:  Nalini M Rajamannan
Journal:  Indian Heart J       Date:  2013-07-25

6.  Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?

Authors:  K Truninger; C H Attenhofer Jost; B Seifert; P R Vogt; F Follath; A Schaffner; R Jenni
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

7.  Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults.

Authors:  Z A Kanafani; S S Kanj; C H Cabell; E Cecchi; A de Oliveira Ramos; T Lejko-Zupanc; P A Pappas; H Giamerellou; D Gordon; C Michelet; P Muñoz; O Pachirat; G Peterson; R-S Tan; P Tattevin; V Thomas; A Wang; F Wiesbauer; D J Sexton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-13       Impact factor: 3.267

8.  The utility of cardiac MRI in diagnosis of infective endocarditis: preliminary results.

Authors:  Memduh Dursun; Sabri Yılmaz; Erdem Yılmaz; Ravza Yılmaz; İmran Onur; Hüseyin Oflaz; Aygün Dindar
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

9.  Awareness of infective endocarditis prophylaxis in parents of children with congenital heart disease: A prospective survey.

Authors:  Parrimala Nath; V Kiran; Sunita Maheshwari
Journal:  Ann Pediatr Cardiol       Date:  2008-01

10.  Usefulness of procalcitonin for diagnosis of infective endocarditis.

Authors:  Matjaz Jereb; Tadeja Kotar; Tomaz Jurca; Tatjana Lejko Zupanc
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.